Work

Priapism before and after hematopoietic stem cell therapy in individuals with sickle cell disease

Year: 2025

Type: article

Source: Blood Advances

DOI: 10.1182/bloodadvances.2025017353

Authors: Jose A. Mejias-Figueroa, Santosh L. Saraf, Clifford M. Takemoto, Mark Rodeghier, Michael R. DeBaun

Institutions: University of Puerto Rico, Medical Sciences Campus, University of Puerto Rico System, University of Illinois Chicago, St. Jude Children's Research Hospital, Vanderbilt University, Vanderbilt University Medical Center

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,800

Funders: Pfizer, Agios Pharmaceuticals, Novo Nordisk, National Heart, Lung, and Blood Institute

Award: Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease

OpenAlex ID: W4413140712

FWCI: 1.292

Cites: 6

Cited by: 2

Related to: 10